Reliable Cardiac biomarkers ST2 Assay Starts with Better Raw Materials
Heart failure (HF) affects more than 64 million people worldwide and remains one of the leading causes of hospitalization and mortality. Despite advances in treatment, many patients are still diagnosed at advanced stages, making early risk assessment and accurate prognosis increasingly important. Cardiac biomarker sST2 (soluble suppression of tumorigenicity 2)